文献速递银屑病与炎症性皮肤病自身免疫性与大疱性皮肤病

中性粒细胞线粒体代谢在炎症性皮肤病中的新作用

Mitochondrial Metabolism in Neutrophils: Emerging Roles in Inflammatory Skin Diseases.
PubMed 文献 · Br J Dermatol · 2026-02-18

本综述总结了中性粒细胞线粒体代谢研究进展,指出中性粒细胞除糖酵解外还具有氧化磷酸化、脂肪酸氧化和谷氨酰胺分解等代谢灵活性,线粒体代谢重编程影响NET形成、ROS生成、趋化和凋亡。在银屑病、皮肤红斑狼疮和贝赫切特病中中性粒细胞线粒体活性显著增加且与疾病活动度相关,靶向线粒体通路的治疗策略受到关注。

要点

  • 中性粒细胞具有氧化磷酸化、脂肪酸氧化等代谢灵活性,线粒体代谢动态重编程。
  • 线粒体ROS通过PAD4依赖性NETosis、炎症小体激活等介导炎症。
  • 银屑病、皮肤红斑狼疮和贝赫切特病中中性粒细胞线粒体活性增加并与疾病活动相关。

核心结论

  • 中性粒细胞线粒体代谢重编程影响NET形成、ROS生成、趋化和凋亡等关键功能。
  • 在银屑病、皮肤红斑狼疮和贝赫切特病中中性粒细胞线粒体活性显著增加且与疾病活动及进展相关。
  • 靶向中性粒细胞线粒体通路的ROS清除剂、线粒体自噬诱导剂和代谢调节剂是有前景的治疗策略。

研究设计与样本

  • 本文为综述,总结中性粒细胞线粒体代谢相关研究进展。

主要发现

  • 中性粒细胞传统上依赖有氧糖酵解,但新兴证据显示其具有氧化磷酸化、脂肪酸氧化和谷氨酰胺分解能力。
  • 线粒体代谢在分化和激活过程中动态重编程。
  • 线粒体功能障碍通过增强ROS产生和驱动NETosis放大病理反应。
  • 线粒体ROS触发PAD4依赖性NETosis、炎症小体激活和促炎细胞因子释放。

临床怎么用

  • 可关注靶向中性粒细胞线粒体通路的治疗策略用于减轻中性粒细胞驱动的皮肤炎症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neutrophils, the most abundant of the circulating leucocytes, play crucial roles in antimicrobial defence, tissue remodelling, and immune regulation. Traditionally regarded as predominantly glycolytic, relying on aerobic glycolysis (the Warburg effect) for rapid ATP generation, neutrophils are now recognised to possess broader metabolic flexibility. Emerging evidence has revealed their capacity for oxidative phosphorylation (OXPHOS), fatty acid oxidation (FAO), and glutaminolysis. As a result, mitochondrial metabolism is dynamically reprogrammed during differentiation and activation. These metabolic shifts in mitochondria profoundly influence essential neutrophil functions, including extracellular trap (NET) formation, reactive oxygen species (ROS) generation, chemotaxis, and apoptosis. In inflammatory skin diseases, mitochondrial dysfunction amplifies pathological responses by enhancing ROS production and driving NETosis. Specifically, in conditions such as psoriasis, cutaneous lupus erythematosus, and Behçet's disease, neutrophil mitochondrial activity is markedly increased, and this increase correlates with disease activity and progression. Notably, mitochondrial ROS have emerged as critical mediators of inflammation, triggering pathways such as PAD4 (peptidylarginine deiminase type 4)-dependent NETosis, inflammasome activation, and proinflammatory cytokine release. Accordingly, therapeutic strategies targeting neutrophil mitochondrial pathways, including ROS scavengers, mitophagy inducers, and metabolic modulators, are gaining increasing attention as promising approaches to mitigate neutrophil-driven skin inflammation. In this review recent advances in understanding mitochondrial metabolism in neutrophils, with particular emphasis on the pathological roles and therapeutic potential of this metabolism as related to inflammatory skin disorders are described.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Zhao F, Guo Y, Jiao Y, et al. Mitochondrial Metabolism in Neutrophils: Emerging Roles in Inflammatory Skin Diseases. Br J Dermatol. 2026. PMID: 41703724. doi:10.1093/bjd/ljag060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。